newsFDA grants orphan drug status to Cellect’s ApoGraft5 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)The FDA has granted orphan drug designation for ApoGraft for the prevention of acute and chronic graft versus host disease...